{
    "nctId": "NCT01372631",
    "briefTitle": "A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins",
    "officialTitle": "A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DEVICE_FEASIBILITY",
    "enrollmentCount": 218,
    "primaryOutcomeMeasure": "Identification of the optical signatures in breast tissue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing a reduction mammoplasty OR\n* Patients undergoing a lumpectomy mastectomy for the treatment of an invasive or non-invasive breast malignancy\n* Age \\> 18\n* Clinically detectable disease either by physical examination or radiographic studies\n* Patients of all ethnic and gender groups will be included. Protocol accrual will be reviewed annually to include a determination of minority and gender representation. If accrual demonstrates under-representation of any group with comparison to disease incidence in that group, appropriate measures will be undertaken to increase participation of patients of that minority or gender group\n* Ability to understand and the willingness to sign a written informed consent document.\n\nExclusion Criteria:\n\n* Patients considered in \"vulnerable\" populations.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}